Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Cipher Pharmaceuticals Inc. CPHRF

Set alert

Price alert · CPHRF

All alert types
9.41 USD +0.06 +0.64%

As of Nov 2, 2:52 PM ET

9.41 Day range 9.55
8.92 52-week range 15.00
YTD
-14.30%
1 year
-10.47%
Open
9.47
Prev close
9.35
Mkt cap
239.16M
Vol
1.60K
Avg vol
5.28K
EPS
1.11
P/E
8.48
More statistics
Low
9.41
High
9.55

3M chart

Chart tools
Interval
1m5m15m30m

Signals (14)
NameDateAgo
SMA: BearishOct 30, 20263 days ago
SMA: BullishOct 29, 20264 days ago
MACD: Buy SignalOct 13, 20262 weeks ago
RSI: OversoldOct 1, 20261 month ago
MACD: Sell SignalSep 25, 20261 month ago
SMA: BearishSep 22, 20261 month ago
SMA: BullishSep 21, 20261 month ago
SMA: BearishSep 18, 20261 month ago
SMA: BullishSep 17, 20261 month ago
MACD: Buy SignalSep 2, 20262 months ago
RSI: OversoldAug 13, 20262 months ago
SMA: BearishAug 12, 20262 months ago
SMA: BearishAug 12, 20262 months ago
MACD: Sell SignalAug 12, 20262 months ago

Financial health

Altman Z-Score

9.07 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

S-5 / 5 overall

  • DCF 5
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 5
  • P/E 3
  • P/B 3

Valuation

P/E 10.1×
FY 2016: -2.0×FY 2017: 22.7×FY 2018: 62.1×FY 2019: 7.9×FY 2020: 4.0×FY 2021: 4.9×FY 2022: 2.8×FY 2023: 5.1×FY 2024: 21.2×FY 2025: 10.1×
FY 2016 5y median 5.1× FY 2025
P/S 5.5×
FY 2016: 1.9×FY 2017: 2.4×FY 2018: 1.5×FY 2019: 1.1×FY 2020: 0.9×FY 2021: 1.7×FY 2022: 3.4×FY 2023: 5.0×FY 2024: 7.4×FY 2025: 5.5×
FY 2016 5y median 5.0× FY 2025
P/B 2.2×
FY 2016: 4.3×FY 2017: 4.2×FY 2018: 1.4×FY 2019: 0.9×FY 2020: 0.6×FY 2021: 1.0×FY 2022: 1.1×FY 2023: 1.3×FY 2024: 2.4×FY 2025: 2.2×
FY 2016 5y median 1.3× FY 2025
P/FCF 9.3×
FY 2016: 7.2×FY 2017: 4.9×FY 2018: 7.2×FY 2019: 3.4×FY 2020: 1.8×FY 2021: 2.7×FY 2022: 6.8×FY 2023: 6.6×FY 2024: 12.6×FY 2025: 9.3×
FY 2016 5y median 6.8× FY 2025
EV/EBITDA 11.5×
FY 2016: 5.6×FY 2017: 4.2×FY 2018: 8.4×FY 2019: 2.3×FY 2020: 0.9×FY 2021: 1.3×FY 2022: 3.5×FY 2023: 5.7×FY 2024: 22.7×FY 2025: 11.5×
FY 2016 5y median 5.7× FY 2025
EV/Sales 5.4×
FY 2016: 2.0×FY 2017: 2.1×FY 2018: 1.8×FY 2019: 1.3×FY 2020: 0.6×FY 2021: 0.8×FY 2022: 2.1×FY 2023: 3.1×FY 2024: 8.1×FY 2025: 5.4×
FY 2016 5y median 3.1× FY 2025
FCF Yield 10.8%
FY 2016: 13.8%FY 2017: 20.5%FY 2018: 13.8%FY 2019: 29.6%FY 2020: 56.2%FY 2021: 36.8%FY 2022: 14.8%FY 2023: 15.3%FY 2024: 7.9%FY 2025: 10.8%
FY 2016 5y median 14.8% FY 2025

Profitability

Gross Margin 65.8%
FY 2016: 88.7%FY 2017: 95.3%FY 2018: 89.8%FY 2019: 87.1%FY 2020: 85.9%FY 2021: 83.2%FY 2022: 80.7%FY 2023: 80.8%FY 2024: 72.2%FY 2025: 65.8%
FY 2016 5y median 80.7% FY 2025
Operating Margin 32.7%
FY 2016: -78.1%FY 2017: 62.6%FY 2018: 23.4%FY 2019: 52.0%FY 2020: 56.4%FY 2021: 53.9%FY 2022: 53.6%FY 2023: 54.5%FY 2024: 23.5%FY 2025: 32.7%
FY 2016 5y median 53.6% FY 2025
Net Margin 54.2%
FY 2016: -96.1%FY 2017: 10.6%FY 2018: 2.4%FY 2019: 14.4%FY 2020: 21.1%FY 2021: 35.4%FY 2022: 128.8%FY 2023: 96.3%FY 2024: 34.6%FY 2025: 54.2%
FY 2016 5y median 54.2% FY 2025
ROE 22.1%
FY 2016: -217.3%FY 2017: 18.7%FY 2018: 2.2%FY 2019: 11.6%FY 2020: 13.9%FY 2021: 19.9%FY 2022: 41.6%FY 2023: 25.3%FY 2024: 11.3%FY 2025: 22.1%
FY 2016 5y median 22.1% FY 2025
ROIC 12.8%
FY 2016: -56.3%FY 2017: 44.6%FY 2018: 4.8%FY 2019: 14.4%FY 2020: 23.7%FY 2021: 21.0%FY 2022: 17.2%FY 2023: 14.3%FY 2024: 5.5%FY 2025: 12.8%
FY 2016 5y median 14.3% FY 2025
ROA 17.8%
FY 2016: -50.6%FY 2017: 6.8%FY 2018: 1.0%FY 2019: 7.0%FY 2020: 10.3%FY 2021: 15.0%FY 2022: 36.1%FY 2023: 23.7%FY 2024: 7.1%FY 2025: 17.8%
FY 2016 5y median 17.8% FY 2025

Growth (YoY)

Revenue 53.9%
FY 2016: 18.4%FY 2017: -1.0%FY 2018: -43.6%FY 2019: -1.3%FY 2020: -3.8%FY 2021: 1.6%FY 2022: -5.8%FY 2023: 2.4%FY 2024: 57.7%FY 2025: 53.9%
FY 2016 FY 2025
Operating Income 114.1%
FY 2016: -46707.4%FY 2017: 179.3%FY 2018: -78.9%FY 2019: 119.2%FY 2020: 4.4%FY 2021: -3.1%FY 2022: -6.2%FY 2023: 4.0%FY 2024: -31.9%FY 2025: 114.1%
FY 2016 FY 2025
EPS (diluted) 132.6%
FY 2016: -2171.4%FY 2017: 111.0%FY 2018: -87.4%FY 2019: 497.0%FY 2020: 50.0%FY 2021: 61.1%FY 2022: 241.4%FY 2023: -19.2%FY 2024: -42.5%FY 2025: 132.6%
FY 2016 FY 2025
Free Cash Flow 54.9%
FY 2016: 5345.7%FY 2017: 82.0%FY 2018: -76.4%FY 2019: 62.1%FY 2020: 44.8%FY 2021: 26.4%FY 2022: -24.0%FY 2023: 52.3%FY 2024: 22.1%FY 2025: 54.9%
FY 2016 FY 2025

Financial Health

Current Ratio 1.1×
FY 2016: 2.5×FY 2017: 2.0×FY 2018: 1.1×FY 2019: 1.0×FY 2020: 2.0×FY 2021: 2.4×FY 2022: 4.1×FY 2023: 9.2×FY 2024: 1.9×FY 2025: 1.1×
FY 2016 5y median 2.4× FY 2025
Quick Ratio 0.8×
FY 2016: 2.4×FY 2017: 2.0×FY 2018: 1.0×FY 2019: 1.0×FY 2020: 1.9×FY 2021: 2.3×FY 2022: 3.8×FY 2023: 8.6×FY 2024: 1.6×FY 2025: 0.8×
FY 2016 5y median 2.3× FY 2025
Debt / Equity 0.0×
FY 2016: 2.0×FY 2017: 0.8×FY 2018: 0.7×FY 2019: 0.3×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.4×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -0.1×
FY 2016: 0.1×FY 2017: -0.5×FY 2018: 1.5×FY 2019: 0.3×FY 2020: -0.5×FY 2021: -1.5×FY 2022: -2.4×FY 2023: -3.4×FY 2024: 1.9×FY 2025: -0.1×
FY 2016 5y median -1.5× FY 2025
Interest Coverage 14.2×
FY 2016: -4.1×FY 2017: 4.8×FY 2018: 5.9×FY 2019: 12.1×FY 2020: 37.8×FY 2021: 128×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 14.2×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31